Charles River Laboratories International Inc. Stock Underperforms Friday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Charles River Laboratories International Inc. (CRL) shares fell 2.10% to $224.35 on Friday, underperforming the broader market and some competitors. While Labcorp and Bio-Techne rose slightly, Alnylam Pharmaceuticals dropped significantly. CRL closed 5.68% below its 52-week high of $237.86. Trading volume was notably lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Charles River Laboratories International Inc. (CRL) slid 2.10% to $224.35 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 1.01% to 7,457.69 and Dow Jones Industrial Average falling 0.77% to 52,146.42.
Charles River Laboratories International Inc. closed 5.68% short of its 52-week high of $237.86, which the company achieved on July 10th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Labcorp Holdings Inc. (LH) rose 0.50% to $283.36, Alnylam Pharmaceuticals Inc. (ALNY) fell 5.54% to $267.47, and Bio-Techne Corp. (TECH) rose 0.49% to $72.12.
Trading volume (708,374) remained 208,203 below its 50-day average volume of 916,577.
Data source: Dow Jones Market Data, FactSet. Data compiled July 17, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-17-26 1716ET